APA (7th ed.) Citation

F, B., S, B., L, M., V, R., T, C., M, L., . . . E, M. (2008). Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia. International journal of clinical practice, 62(12), 1864. https://doi.org/10.1111/j.1742-1241.2008.01779.x

Chicago Style (17th ed.) Citation

F, Bogazzi, et al. "Treatment with Low Doses of Cabergoline Is Not Associated with Increased Prevalence of Cardiac Valve Regurgitation in Patients with Hyperprolactinaemia." International Journal of Clinical Practice 62, no. 12 (2008): 1864. https://doi.org/10.1111/j.1742-1241.2008.01779.x.

MLA (9th ed.) Citation

F, Bogazzi, et al. "Treatment with Low Doses of Cabergoline Is Not Associated with Increased Prevalence of Cardiac Valve Regurgitation in Patients with Hyperprolactinaemia." International Journal of Clinical Practice, vol. 62, no. 12, 2008, p. 1864, https://doi.org/10.1111/j.1742-1241.2008.01779.x.